Clinical Outcomes of Pectoralis Major Tendon Repair with and without Platelet‐Rich Plasma
Authors:
Open Access
- 6 September 2022
- journal article
- Published by Wiley in Arthroscopy, Sports Medicine, and Rehabilitation
- Vol. 4 (5) , e1739-e1746
Abstract
Purpose: To assess clinical outcomes following pectoralis major tendon (PMT) repairs and to compare outcomes of PMT repairs augmented with and without leukocyte‐poor platelet‐rich plasma (LP‐PRP). Methods: A retrospective review of prospectively collected data was performed of patients who underwent a PMT repair from May 2007 to June 2019 with a minimum of 2‐year follow‐up. Exclusion criteria included revision PMT repair, PMT reconstruction, and concomitant repair of another glenohumeral tendon/ligament. LP‐PRP was injected surrounding the PMT repair before wound closure. Patient‐reported outcome (PRO) data were collected preoperatively and evaluated at final follow‐up using the American Shoulder and Elbow Surgeons Score (ASES), Single Assessment Numeric Evaluation Score (SANE), Quick Disabilities of the Arm, Shoulder and Hand Score (QuickDASH), and Short Form 12 physical component summary (SF‐12 PCS), patient satisfaction with outcomes. Results: Twenty‐three men (mean age, 38.6 years; range, 20.5‐64.3 years) were included in the final analysis. Mean time from injury to surgery was 30 days (range, 3‐123 days). Follow‐up was obtained for 16 of 23 patients (70%) at a mean of 5.1 years (range 2.0‐13.0 years). Significant improvement in PROs was observed (ASES: 59.0 → 92.4, P = .008; SANE: 44.4 → 85.9, P = .018; QuickDASH: 44.4 → 8.5, P = .018; and SF‐12 PCS: 42.5 → 52.6, P = .008). Median satisfaction was 9 of 10 (range, 6‐10). Patients receiving LP‐PRP had superior ASES (99.6 vs 83.0, P = .001), SANE (94.8 vs 74.6, P = .005), QuickDASH (0.24 vs 19.1, P = .001), and patient satisfaction (10 vs 9, P = .037) scores compared with those without PRP. PROs were unchanged based on chronicity, mechanism of injury, or tear location. One patient had revision surgery at 3.4 years due to adhesions. Conclusions: PMT repair produces improved PROs at final follow‐up when compared with preoperative values. Level of Evidence: Level III, retrospective comparative therapeutic trial.Keywords
Funding Information
- Steadman Philippon Research Institute
- Johnson and Johnson
- DePuy Mitek
- Arthrex
- Arthroscopy Association of North America
- American Academy of Orthopaedic Surgeons
- American Orthopaedic Society for Sports Medicine
- American Shoulder and Elbow Surgeons
- International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine
- Steadman Philippon Research Institute
- Siemens
- Arthrex
- American Academy of Orthopaedic Surgeons
This publication has 22 references indexed in Scilit:
- HGF Mediates the Anti-inflammatory Effects of PRP on Injured TendonsPLOS ONE, 2013
- Defining the Terms Acute and Chronic in Orthopaedic Sports InjuriesThe American Journal of Sports Medicine, 2013
- Platelet-Rich Plasma Promotes the Proliferation of Human Muscle Derived Progenitor Cells and Maintains Their StemnessPLOS ONE, 2013
- Platelet‐Rich Plasma in Tendon Models: A Systematic Review of Basic Science LiteratureArthroscopy, 2013
- Pectoralis Major Muscle Rupture Repair: Technique Using Unicortical ButtonsArthroscopy Techniques, 2012
- A systematic review and comprehensive classification of pectoralis major tearsJournal of Shoulder and Elbow Surgery, 2012
- Injuries to the Pectoralis Major MuscleThe American Journal of Sports Medicine, 2010
- Pectoralis Major Muscle Rupture in AthletesThe American Journal of Sports Medicine, 2009
- Rupture of the pectoralis major: a meta‐analysis of 112 casesKnee Surgery, Sports Traumatology, Arthroscopy, 2000
- Closed Injuries of the Pectoralis Major Muscle1980